JP Morgan Chase
PRAH

JP Morgan Chase’s PRA Health Sciences, Inc. PRAH Stock Holding History

JP Morgan Chase’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-697,656
Closed -$115M – 7077
2021
Q2 		$115M Buy
697,656
+334,284
+92% +$55.8M 0.01% 833
2021
Q1 		$55.7M Buy
363,372
+245,468
+208% +$33.3M 0.01% 1113
2020
Q4 		$14.8M Buy
117,904
+25,865
+28% +$2.89M ﹤0.01% 1879
2020
Q3 		$9.04M Sell
92,039
-29,109
-24% -$2.97M ﹤0.01% 2113
2020
Q2 		$11.8M Sell
121,148
-89,588
-43% -$8.34M ﹤0.01% 1765
2020
Q1 		$17.5M Buy
210,736
+131,254
+165% +$12.8M ﹤0.01% 1345
2019
Q4 		$8.83M Sell
79,482
-31,723
-29% -$3.26M ﹤0.01% 2215
2019
Q3 		$11M Buy
111,205
+49,999
+82% +$4.97M ﹤0.01% 2066
2019
Q2 		$5.87M Sell
61,206
-57,698
-49% -$5.51M ﹤0.01% 2505
2019
Q1 		$13.1M Buy
118,904
+28,963
+32% +$3.03M ﹤0.01% 1830
2018
Q4 		$8.27M Sell
89,941
-30,249
-25% -$3.06M ﹤0.01% 2172
2018
Q3 		$13.2M Buy
120,190
+43,542
+57% +$4.53M ﹤0.01% 1973
2018
Q2 		$7.16M Sell
76,648
-3,440
-4% -$296K ﹤0.01% 2411
2018
Q1 		$6.64M Sell
80,088
-117,252
-59% -$10.4M ﹤0.01% 2340
2017
Q4 		$18M Buy
197,340
+142,764
+262% +$11.9M ﹤0.01% 1660
2017
Q3 		$4.14M Sell
54,576
-60,831
-53% -$4.6M ﹤0.01% 2689
2017
Q2 		$8.66M Buy
115,407
+10,260
+10% +$711K ﹤0.01% 2073
2017
Q1 		$6.86M Buy
105,147
+5,880
+6% +$346K ﹤0.01% 2200
2016
Q4 		$5.47M Buy
99,267
+48,483
+95% +$2.66M ﹤0.01% 2377
2016
Q3 		$2.87M Sell
50,784
-40,590
-44% -$1.99M ﹤0.01% 2582
2016
Q2 		$3.81M Buy
91,374
+90,409
+9,369% +$4.17M ﹤0.01% 2454
2016
Q1 		$41K Buy
+965
New +$40.8K ﹤0.01% 3943
2015
Q1 		– Sell
-309,425
Closed -$7.49M – 4346
2014
Q4 		$7.49M Buy
+309,425
New +$6.97M ﹤0.01% 2141

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

JP Morgan Chase's PRAH Position: Q3 2021 in Review

JP Morgan Chase sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 697,656 shares — an estimated $115M sold.

JP Morgan Chase first reported a position in PRAH in Q4 2014 and held it in 23 quarters. The position peaked at $115M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • JP Morgan Chase reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Chase sold 697,656 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $115M.
  • JP Morgan Chase first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 23 quarters.
  • JP Morgan Chase's PRA Health Sciences, Inc. position peaked at $115M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.